CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Clinical trial NCT06304857 · RECRUITING
Trial details
- NCT number
- NCT06304857
- Sponsor
- 4th Military Clinical Hospital with Polyclinic, Poland
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-15
- Primary completion
- 2026-12-31
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.